None of the 29 investors followed here reported a position in ASH in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a ASH trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 20, 2026 | Musa Osama MChief Technology Officer | — | 10.4K | — |
| Aug 10, 2026 | Lampkin Robin EGeneral Counsel | Conversion of Exercise of derivative security at price 74.58 per share. | 1.8K | $134.69K |
| Jul 28, 2026 | Musa Osama MChief Technology Officer | Conversion of Exercise of derivative security at price 57.96 per share. | 1.3K | $73.44K |
| Jul 26, 2026 | Assis Alessandra FaccinOfficer | Conversion of Exercise of derivative security at price 66.38 per share. | 3.2K | $213.41K |
| May 7, 2026 | Minicucci James POfficer | Conversion of Exercise of derivative security at price 55.01 per share. | 4.3K | $237.09K |
| Jan 20, 2026 | Kulkarni Ashish KDirector | — | 2.1K | — |
| Nov 16, 2025 | Musa Osama MChief Technology Officer | Conversion of Exercise of derivative security at price 49.60 per share. | 976 | $48.41K |
| Nov 16, 2025 | Drury EileenOfficer | Conversion of Exercise of derivative security at price 49.60 per share. | 567 | $28.12K |
| Nov 16, 2025 | Lampkin Robin EGeneral Counsel | Conversion of Exercise of derivative security at price 49.60 per share. | 239 | $11.85K |
| Nov 16, 2025 | Whitaker WilliamChief Financial Officer | Conversion of Exercise of derivative security at price 49.60 per share. | 107 | $5.31K |
| Nov 16, 2025 | Richardson SamuelOfficer | Conversion of Exercise of derivative security at price 49.60 per share. | 107 | $5.31K |
| Nov 16, 2025 | Novo GuillermoChief Executive Officer | Conversion of Exercise of derivative security at price 49.60 per share. | 6.1K | $303.65K |
| Nov 13, 2025 | Musa Osama MChief Technology Officer | Conversion of Exercise of derivative security at price 51.51 - 53.10 per share. | 3.5K | $181.68K |
| Nov 13, 2025 | Drury EileenOfficer | Conversion of Exercise of derivative security at price 51.51 - 53.10 per share. | 2.2K | $112.63K |
| Nov 13, 2025 | Lampkin Robin EGeneral Counsel | Conversion of Exercise of derivative security at price 51.51 - 53.10 per share. | 2.1K | $111.71K |
| Nov 13, 2025 | Minicucci James POfficer | Conversion of Exercise of derivative security at price 51.51 - 53.10 per share. | 2.2K | $117.26K |
| Nov 13, 2025 | Whitaker WilliamChief Financial Officer | Conversion of Exercise of derivative security at price 51.51 - 53.10 per share. | 585 | $30.50K |
| Nov 13, 2025 | Richardson SamuelOfficer | Conversion of Exercise of derivative security at price 51.51 - 53.10 per share. | 374 | $19.50K |
| Nov 13, 2025 | Novo GuillermoChief Executive Officer | Conversion of Exercise of derivative security at price 51.51 - 53.10 per share. | 18.1K | $949.16K |
| Nov 12, 2025 | Assis Alessandra FaccinOfficer | Conversion of Exercise of derivative security at price 53.10 per share. | 1.3K | $71.15K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 4.2 | 2.0 | -10.8 | -4.2 | 8.7 | 13.8 | 10.2 | 1.0 | -7.4 | 4.2 | +20.6% | ||
| 2025 | -11.2 | -4.2 | -2.5 | -8.3 | -9.0 | 1.6 | 2.5 | 8.9 | -14.7 | 2.1 | 8.2 | 10.9 | −17.9% |
| 2024 | 11.0 | 0.0 | 4.0 | -2.1 | 5.1 | -5.7 | 2.3 | -7.4 | -2.8 | -2.8 | -7.7 | -8.5 | −15.2% |
| 2023 | 1.6 | -6.9 | 0.9 | -1.1 | -16.5 | 2.4 | 5.1 | -5.2 | -5.7 | -6.2 | 4.3 | 5.5 | −21.6% |
| 2022 | -10.8 | -3.9 | 6.6 | 6.7 | 2.0 | -3.7 | -2.5 | 1.3 | -6.7 | 10.5 | 6.6 | -3.9 | −0.1% |
| 2021 | 1.0 | 5.2 | 5.5 | -2.9 | 10.0 | -7.7 | -2.8 | 7.1 | -2.2 | 7.7 | 5.3 | 6.5 | +35.9% |
| 2020 | -3.3 | -3.3 | -30.0 | 23.2 | 8.9 | 2.9 | 9.2 | -2.4 | -3.8 | -1.6 | 7.7 | 5.4 | +3.5% |
| 2019 | 7.0 | 1.9 | 1.0 | 3.1 | -7.0 | 6.8 | -0.6 | -7.9 | 5.2 | 0.4 | -7.3 | 6.7 | +7.8% |
| 2018 | 2.0 | -2.4 | -1.5 | -5.2 | 17.4 | 0.6 | 5.0 | 2.5 | -0.4 | -11.8 | 10.7 | -13.3 | −0.3% |
| 2017 | 8.9 | 1.4 | 2.6 | -0.3 | 10.1 | -0.9 | -1.4 | -4.5 | 5.4 | 4.0 | 8.8 | -3.8 | +33.2% |
| 2016 | -7.7 | 0.6 | 15.4 | 1.5 | 1.6 | 1.2 | -1.3 | 3.4 | -1.0 | -3.6 | 0.9 | -3.0 | +6.4% |
| 2015 | -1.0 | 7.7 | -0.2 | -0.7 | 0.8 | -4.3 | -6.2 | -8.2 | -4.1 | 9.0 | 2.7 | -8.8 | −14.2% |
| 2014 | -4.4 | 1.7 | 5.4 | -2.9 | 6.6 | 5.6 | -3.8 | 2.5 | -2.9 | 3.8 | 5.5 | 5.0 | +23.4% |
| 2013 | -2.4 | -0.7 | -4.7 | 14.7 | 4.4 | -6.1 | 4.0 | 0.4 | 6.0 | 0.1 | -1.6 | 6.5 | +20.7% |
| 2012 | 10.3 | 0.8 | -3.9 | 7.9 | -2.9 | 8.4 | 1.6 | 4.6 | -2.8 | -0.6 | -0.3 | 13.4 | +40.7% |
| 2011 | 14.2 | -3.0 | 2.6 | 7.5 | 10.1 | -5.4 | -5.2 | -13.4 | -16.7 | 20.0 | 5.0 | 2.8 | +12.4% |
| 2010 | 2.0 | 16.5 | 12.1 | 12.9 | -10.0 | -13.4 | 9.5 | -8.6 | 5.0 | 5.9 | -1.5 | -0.0 | +28.4% |
| 2009 | -23.7 | -26.3 | 74.8 | 112.6 | 22.0 | 4.7 | 18.1 | 10.7 | 17.8 | -20.1 | 4.0 | 10.3 | +277.0% |
| 2008 | -4.0 | -3.0 | 7.1 | 12.1 | 1.2 | -10.2 | -13.3 | -2.0 | -28.6 | -22.7 | -57.7 | 10.1 | −77.8% |
| 2007 | 0.5 | -5.8 | 0.2 | -8.6 | 0.6 | 6.0 | -4.5 | -2.1 | 0.7 | -2.5 | -16.1 | -3.7 | −31.4% |
Ashland Inc. provides additives and specialty ingredients in the North and Latin America, Europe, Asia Pacific, and internationally. It operates through Life Sciences, Personal Care, Specialty Additives, and Intermediates segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubilizers, and tablet binders; and nutrition solutions, such as thickeners, stabilizers, emulsifiers, and additives; agricultural chemicals; diagnostic films; and fine chemicals. Its Personal Care segment provides a range of natural, nature-derived, biodegradable, and performance ingredients; solutions for toothpastes, mouth washes and rinses, denture cleaning, and care for teeth; and household supplies nature-derived rheology ingredients, biodegradable surface wetting agents, performance encapsulates, and specialty polymers. The Specialty Additives segment offers rheology modifiers, foam control agents, surfactants and wetting agents, pH neutralizers, advanced ceramics used in catalytic converters, environmental filters, ingredients for the manufacturing of ceramic capacitors, plasma display panels and solar cells, ingredients for textile printing, thermoplastic metals, and alloys for welding. Its Intermediates segment produces 1,4 butanediol and related derivatives, including n-methylpyrrolidone. It offers its products to customers in a range of consumer and industrial markets, such as architectural coatings, construction, energy, food and beverage, personal care, and pharmaceutical. The company was formerly known as Ashland Global Holdings Inc. and changed its name to Ashland Inc. in August 2022. Ashland Inc. was founded in 1924 and is headquartered in Wilmington, Delaware.
Buy / hold / sell counts